Search results
What Happens to the Human Body After 200 Vaccines?
Technology Networks· 2 weeks agoLast month a story about a 62-year-old male from Magdeburg made headlines after he claimed to have received 217 vaccines against SARS-CoV
A one-shot vaccine for COVID, flu and future viruses? Researchers say it's coming
Salon via Yahoo News· 6 days agoBAY ISMOYO/AFP via Getty Images At the beginning of the pandemic, many people hoped that infections...
Texas Biomed researching vaccines and treatments for highly pathogenic avian influenza
Valley City Times Record· 6 days agoResearchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian ...
Physicist Studying SARS-CoV-2 Virus Believes He Has Found Hints We Are Living In A Simulation
IFLScience· 1 week agoA physicist studying mutations of the SARS-CoV-2 virus claims to have found evidence for a new law...
Nicole Karlis, Salon
The Raw Story· 2 weeks agoOf course, nobody can predict with perfect accuracy what COVID-19 will look like eighty years hence. For example, experts know that the virus can mutate to become more contagious ...
COVID-19 Immunity May Last Six Months or More | HHMI
Howard Hughes Medical Institute· 2 weeks agoSix months after infection, those antibodies become both more potent and better at combating mutated versions of the virus, called SARS-CoV< ...
CureVac (NASDAQ:CVAC) Shares Gap Up to $2.44
ETF DAILY NEWS· 9 hours agoCureVac (NASDAQ:CVAC – Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $2.44, but opened at $2.51. CureVac shares last traded at $2.49, with ...
The pandemic cost 7 million lives, but talks to prevent a repeat stall
Stars and Stripes· 3 days agoThe costs of not reaching one? An unknown future pathogen could have far more devastating...
Fauci hosted 2013 meeting where Baric laid out plans to make coronaviruses more lethal
World Tribune· 5 days agoOn June 24, 2013, the National Institutes of Health (NIH) hosted a meeting featuring Ralph Baric who...
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 2 days agoOne study published in PLOS Pathogens in 2022 found that long COVID patients had 100 times the...
